Literature DB >> 2876231

First-trimester fetal diagnosis for haemoglobinopathies: report on 200 cases.

J M Old, A Fitches, C Heath, S L Thein, D J Weatherall, R Warren, C McKenzie, C H Rodeck, B Modell, M Petrou.   

Abstract

First-trimester prenatal diagnosis by DNA analysis was found to be possible in 224 (80%) of 281 families at risk of having a child with beta-thalassaemia major. 200 prenatal diagnoses, mainly for beta-thalassaemia or sickle-cell anaemia, were made by means of chorionic villus sampling and fetal DNA analysis. The overall fetal loss rate was 6.7%, the majority being in the first half of the programme. There was one misdiagnosis. Prenatal diagnosis was also carried out successfully for both pairs of twins in two pregnancies. Comparison of these results with 53 prenatal diagnoses made with DNA prepared from amniotic fluid suggests that the first-trimester procedure is more reliable. If further experience confirms that chorionic villus sampling has an acceptably low risk for both mother and fetus it will largely replace other methods for prenatal diagnosis of the haemoglobin disorders and other single-gene conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876231     DOI: 10.1016/s0140-6736(86)90296-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Services for thalassaemia as a model for cost-benefit analysis of genetics services.

Authors:  B Modell; A M Kuliev
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  The frequency of consanguineous marriage among British Pakistanis.

Authors:  A Darr; B Modell
Journal:  J Med Genet       Date:  1988-03       Impact factor: 6.318

3.  Molecular genetics as a diagnostic service.

Authors:  P S Harper
Journal:  J Med Genet       Date:  1989-04       Impact factor: 6.318

4.  Factors affecting the uptake of prenatal diagnosis for sickle cell disease.

Authors:  M Petrou; M Brugiatelli; R H Ward; B Modell
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

5.  Prenatal screening for cystic fibrosis carriers: an economic evaluation.

Authors:  P T Rowley; S Loader; R M Kaplan
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

6.  An assessment of the usefulness of electrophoretic variants of esterase-D in the antenatal diagnosis of retinoblastoma in the United Kingdom.

Authors:  J K Cowell; M Jay; P Rutland; J Hungerford
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.